ATOSSA THERAPEUTICS, INC. Litigation Settlement, Amount (Deprecated 2017-01-31)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Litigation Settlement, Amount (Deprecated 2017-01-31) of $1.80 million for the 0-month period ending 2016-08-04, per its 10-K/A filed 2017-03-21.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmount · last filed 2017-03-21
- 2016-08-04: Litigation Settlement, Amount (Deprecated 2017-01-31) 0 month $1.80M.
| Period end | Litigation Settlement, Amount (Deprecated 2017-01-31) 0 month |
|---|---|
| 2016-08-04 | $1.80M 10-K/A · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |